Overview

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of repeated dosing of BIA 9-1067 on the levodopa pharmacokinetics, in comparison to placebo and entacapone.
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Carbidopa
Entacapone
Levodopa
Opicapone